Population
Human platelet-rich plasma in vitro
Design
Preclinical
Authors
Loading...
May link sympathetic activation to thrombotic risk; hypothesis-generating for human alpha(2A) targeting.
Alpha(2A)-adrenoceptor activation by epinephrine or norepinephrine decelerates platelet deaggregation, which may contribute to increased thrombotic risk in certain disease states.
Todd Schwarz Saul Maayani (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: